机译:人类单克隆抗体作为候选药物对新兴病毒和HIV-1的治疗
Interactions;
Group,;
National;
Cancer;
Institute,;
National;
Institutes;
of;
Health,;
Frederick,;
Maryland;
21702,;
USA;
Research;
Program,;
Science;
Applications;
International;
Corporation-Frederick,;
Inc.,;
Frederick,;
Maryland;
21702,;
USA;
of;
Microbiology;
and;
Immunology,;
Uniformed;
Services;
University,;
Bethesda,;
MD;
20814,;
USA;
for;
Emerging;
Infectious;
Diseases,;
Wuhan;
Institute;
of;
Virology,;
Chinese;
Academy;
of;
Sciences,;
Wuhan,;
Hubei;
430072,;
China;
人类免疫缺陷病毒; 单克隆抗体; 病毒性疾病; HIV-1; 治疗; SARS-CoV; 呼吸系统综合症; 西尼罗河病毒;